ERF Eurofins Scientific SE
75.54EUR+0.91%Mkt Cap: 14.05B $P/E: 26.231d ago
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and huma…
Industry Peers
Diagnostics & Research$250.23BUSDP/E 36.4
$155.51BUSDP/E 39.4
$61.35BUSD
$45.82BUSDP/E 38.1
$48.29BUSDP/E 33.8
$44.35BUSDP/E 54.8
$43.80BUSDP/E 33.1
$43.21BUSDP/E 111.4
$41.58BUSDP/E 37.0
$30.89BUSDP/E 34.7
$25.63BUSDP/E 24.7
$25.12BUSD
$25.03BUSDP/E 25.5
$17.56BUSDP/E 75.3
$17.32BUSDP/E 36.4
$14.84BUSD
$12.99BUSDP/E 177.2
$10.02BUSDP/E 20.0
$9.46BUSDP/E 23.2
$6.88BUSD
| Headline | Source | Time |
|---|---|---|
Yesterday | ||
IIdeal Investisseur | ||
Older | ||
IIdeal Investisseur | ||
 Eurofins Scientific (ENXTPA:ERF) Is A Major Central Labs Market Competitor Eurofins Scientific (ENXTPA:ERF) has been highlighted as a major competitor in a new global Central Labs market report running through 2032. The study links sector expansion to AI driven analytics, precision medicine programs and greater outsourcing of clinical trial lab work. Eurofins is cited among leading providers as decentralized and hybrid clinical trial models increase demand for coordinated global lab services. The spotlight on Eurofins in this long term Central Labs growth report... | ||
IIdeal Investisseur | ||